These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11702910)

  • 1. Medical treatment of overactive bladder.
    Rackley R; Wein A; Nelson D
    Mayo Clin Proc; 2001 Nov; 76(11):1179-80. PubMed ID: 11702910
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
    Rovner ES; Wein AJ
    BJU Int; 2000 Oct; 86 Suppl 2():44-53; discussion 53-4. PubMed ID: 11501617
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticholinergic drugs for overactive bladder.
    Kripke C
    Am Fam Physician; 2006 Jan; 73(1):66. PubMed ID: 16417066
    [No Abstract]   [Full Text] [Related]  

  • 4. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
    Hartnett NM; Saver BG
    J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
    [No Abstract]   [Full Text] [Related]  

  • 5. The newer antimuscarinic drugs: bladder control with less dry mouth.
    Appell RA
    Cleve Clin J Med; 2002 Oct; 69(10):761, 765-6, 768-9. PubMed ID: 12371799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrol LA and Diropan XL for overactive bladder.
    Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    de Jong TP
    J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695627
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Jorgensen TM
    J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695626
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Yang SS
    J Urol; 2009 Oct; 182(4 Suppl):2038-9; discussion 2039. PubMed ID: 19695625
    [No Abstract]   [Full Text] [Related]  

  • 10. New treatment options for overactive bladder and incontinence.
    Newman DK
    Director; 2002; 10(3):74-6. PubMed ID: 12116753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].
    Deng YJ; Ma G; Guo YF; Ge Z; Lu RG; Wang LX; Zhu HB; Chen CJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jan; 13(1):26-8. PubMed ID: 21251382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication update.
    Slagle M
    South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolterodine for the treatment of daytime incontinence in children.
    Greenfield SP
    J Urol; 2005 Apr; 173(4):1064. PubMed ID: 15758701
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary incontinence--treatment].
    Hader C; Welz-Barth A; Keller T
    Dtsch Med Wochenschr; 2003 Apr; 128(14):750-2. PubMed ID: 12673531
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Athanasopoulos AA; Perimenis PS
    BJU Int; 2005 May; 95(7):1117-8. PubMed ID: 15839945
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates.
    Nitz NM; Jumadilova Z; Darkow T; Frytak JR; Bavendam T
    Am J Manag Care; 2005 Jul; 11(4 Suppl):S130-9. PubMed ID: 16161386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHARMAC responds on tolterodine for overactive bladder.
    Moodie P
    N Z Med J; 2005 Feb; 119(1229):U1871. PubMed ID: 16498471
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
    Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Overactive bladder. New anticholinergic drug controls urinary urge].
    MMW Fortschr Med; 2004 Jul; 146(27-28):51. PubMed ID: 15526670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.